Tolerability and pharmacokinetics of leritrelvir in Chinese participants with severe renal impairment and healthy matched control subjects

Documenti analoghi

• The effect of severe renal impairment on the pharmacokinetics, safety and tolerability of mitiperstat
  di: Chandrali S. Bhattacharya, et al.
  Pubblicazione: (2024)
• Safety and pharmacokinetics of a novel potent GABA analogue crisugabalin in Chinese subjects with various degrees of renal impairment
  di: Shibeilei Lin, et al.
  Pubblicazione: (2025)
• Effect of fluconazole on the pharmacokinetics of ainuovirine in healthy adult subjects
  Pubblicazione: (2024)
• Clinical study of the pharmacokinetics and pharmacodynamics of Xininurad tablets in patients with renal impairment
  di: Xiaoni Wang, et al.
  Pubblicazione: (2025)
• Physiologically based pharmacokinetic model for oxcarbazepine active metabolite to predict pharmacokinetics in paediatric patients with renal impairment and adjust dosages
  di: Cheng‐jie Ke, et al.
  Pubblicazione: (2025)